Endocrinology focuses on hormonal system and metabolic health. Learn about the diagnosis and treatment of diabetes, thyroid disorders, and adrenal conditions.
Send us all your questions or requests, and our expert team will assist you.
Treatment and management of gestational diabetes is a coordinated effort that balances maternal health with fetal development. This page is designed for expectant mothers, their families, and healthcare professionals seeking an in‑depth, evidence‑based approach to caring for gestational diabetes. Worldwide, approximately 7 % of pregnancies are affected by this condition, highlighting the importance of timely and effective care. Here you will find a step‑by‑step guide covering diagnosis, lifestyle modifications, medication options, continuous monitoring, and postpartum follow‑up, all tailored to the needs of international patients receiving care at Liv Hospital.
Our comprehensive overview integrates the latest clinical guidelines with practical tools, ensuring you can make informed decisions throughout pregnancy and beyond. Whether you are planning your first prenatal visit or preparing for delivery, the information below will support a safe and healthy journey.
Gestational diabetes mellitus (GDM) is a form of glucose intolerance that emerges during pregnancy, typically in the second or third trimester. It results from hormonal changes that increase insulin resistance, challenging the pancreas’s ability to regulate blood sugar. While many women return to normal glucose levels after delivery, untreated GDM can lead to complications such as macrosomia, pre‑eclampsia, and a higher risk of developing type 2 diabetes later in life.
Recognizing these risk factors enables early screening and proactive treatment and management strategies, reducing the likelihood of adverse outcomes for both mother and baby.
Accurate diagnosis is the cornerstone of effective treatment and management. The standard approach involves a two‑step screening process: an initial glucose challenge test followed by a diagnostic oral glucose tolerance test (OGTT) if the first test is abnormal.
Test | Procedure | Diagnostic Thresholds
|
|---|---|---|
1‑Hour Glucose Challenge (50 g) | 50 g glucose load, plasma glucose measured after 1 hour | ≥ 140 mg/dL (≥ 7.8 mmol/L) – proceed to OGTT |
3‑Hour OGTT (100 g) | Fasting, then 100 g glucose load; measurements at fasting, 1 h, 2 h, 3 h | Fasting ≥ 95 mg/dL, 1 h ≥ 180 mg/dL, 2 h ≥ 155 mg/dL, 3 h ≥ 140 mg/dL (any two values confirm GDM) |
Following diagnosis, a multidisciplinary team—including endocrinologists, obstetricians, dietitians, and diabetes educators—creates a personalized care plan that forms the basis of ongoing treatment and management.
Dietary modification and regular exercise are the first line of treatment and management for most women with gestational diabetes. These interventions aim to achieve euglycemia while supporting fetal growth.
Regular follow‑up with a dietitian ensures that nutritional plans remain adaptable to changing pregnancy needs, reinforcing the overall treatment and management approach.
When lifestyle measures alone cannot maintain target glucose levels, medication becomes necessary. The choice of therapy depends on gestational age, severity of hyperglycemia, and patient preference.
Medication | Placental Transfer | Typical Use Case | Advantages | Considerations
|
|---|---|---|---|---|
Insulin | None | First‑line when diet/exercise insufficient | Precise dosing, well‑studied safety | Requires injections and dose adjustments |
Metformin | Partial | Women preferring oral therapy | Oral administration, weight neutral | Long‑term infant outcomes still under study |
Glyburide | Significant | Alternative oral option | Convenient oral dosing | Potential for higher fetal insulin exposure |
Choosing the appropriate pharmacologic route is a critical component of comprehensive treatment and management, and Liv Hospital’s endocrinology specialists tailor therapy to each patient’s clinical profile.
Continuous glucose monitoring (CGM) or self‑monitoring of blood glucose (SMBG) provides real‑time feedback, allowing rapid adjustments to diet, activity, or medication.
Time Point | Target Range (mg/dL) | Target Range (mmol/L)
|
|---|---|---|
Fasting | 70–95 | 3.9–5.3 |
1‑Hour Post‑Meal | 100–140 | 5.6–7.8 |
2‑Hour Post‑Meal (if used) | ≤ 120 | ≤ 6.7 |
Regular prenatal visits every 2–4 weeks (more frequent if glycemic control is unstable) enable the care team to review glucose logs, adjust therapy, and assess fetal growth via ultrasound. This systematic treatment and management schedule reduces the risk of complications and promotes optimal outcomes.
Gestational diabetes typically resolves after delivery, but women remain at elevated risk for type 2 diabetes and cardiovascular disease. Structured postpartum care is essential for early detection and prevention.
Liv Hospital provides coordinated postpartum services, including endocrinology follow‑up, nutritional counseling, and access to wellness programs, ensuring a seamless transition from pregnancy‑focused treatment and management to lifelong health maintenance.
Liv Hospital offers JCI‑accredited, internationally recognized care for gestational diabetes, supported by a dedicated multilingual team that handles appointments, transportation, interpreter services, and accommodation. Our state‑of‑the‑art facilities combine cutting‑edge diagnostics with personalized treatment plans, ensuring that every international patient receives safe, compassionate, and culturally sensitive care throughout pregnancy and beyond.
Ready to start your personalized gestational diabetes care journey? Contact Liv Hospital today to schedule a comprehensive consultation and experience seamless, world‑class support from the moment you arrive in Istanbul.
Liv Hospital Ulus
Assoc. Prof. MD. Seda Turgut
Endocrinology and Metabolism
Liv Hospital Ulus
Prof. MD. Demet Yetkin
Endocrinology and Metabolism
Liv Hospital Vadistanbul
Prof. MD. Berçem Ayçiçek
Endocrinology and Metabolism
Liv Hospital Vadistanbul
Prof. MD. Gönül Çatlı
Pediatric Endocrinology
Liv Hospital Vadistanbul
Prof. MD. Kubilay Ükinç
Endocrinology and Metabolism
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Sevil Arı Yuca
Pediatric Endocrinology and Metabolic Diseases
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ufuk Özuğuz
Endocrinology and Metabolism
Liv Hospital Bahçeşehir
Spec. MD. Hüseyin Çelik
Endocrinology and Metabolism
Liv Hospital Topkapı
Prof. MD. Mehmet Aşık
Endocrinology and Metabolism
Liv Hospital Topkapı
Prof. MD. Nujen Çolak Bozkurt
Endocrinology and Metabolism
Liv Hospital Ankara
Prof. MD. Banu Aktaş Yılmaz
Endocrinology and Metabolism
Liv Hospital Ankara
Prof. MD. Peyami Cinaz
Pediatric Endocrinology
Liv Hospital Ankara
Prof. MD. Serdar Güler
Endocrinology and Metabolism
Liv Hospital Ankara
Spec. MD. Elif Sevil Alagüney
Endocrinology and Metabolism
Liv Hospital Gaziantep
Prof. MD. Zeynel Beyhan
Endocrinology and Metabolic Diseases
Liv Hospital Gaziantep
Spec. MD. Tahsin Özenmiş
Endocrinology and Metabolism
Liv Hospital Samsun
Assoc. Prof. MD. Gülçin Cengiz Ecemiş
Endocrinology and Metabolism
Liv Hospital Samsun
Spec. MD. Esra Tutal
Endocrinology and Metabolic Diseases
Liv Bona Dea Hospital Bakü
MD. FİDAN QULU
Endocrinology and Metabolism
Spec. MD. Zümrüt Kocabey Sütçü
Pediatric Endocrinology
Liv Hospital Ulus + Liv Hospital Vadistanbul + Liv Hospital Topkapı
Prof. MD. Cengiz Kara
Pediatric Endocrinology
Send us all your questions or requests, and our expert team will assist you.
Gestational diabetes mellitus (GDM) appears in the second or third trimester when hormonal changes increase insulin resistance. Screening begins with a 1‑hour 50 g glucose challenge; a result of 140 mg/dL or higher triggers a diagnostic 3‑hour 100 g oral glucose tolerance test. Two or more abnormal values (fasting ≥95 mg/dL, 1‑hour ≥180 mg/dL, 2‑hour ≥155 mg/dL, 3‑hour ≥140 mg/dL) confirm GDM. Early detection allows timely lifestyle and medical interventions to protect both mother and baby.
Nutrition guidelines recommend spreading carbs across three meals and 2‑3 snacks, emphasizing complex carbs, fiber‑rich vegetables, lean proteins, and portion control using the plate method. Physical activity should include at least 150 minutes of moderate aerobic exercise weekly (e.g., brisk walking, swimming) plus strength training twice a week, avoiding high‑impact activities that could cause falls. These measures aim to maintain euglycemia while supporting fetal growth.
If self‑monitoring shows persistent hyperglycemia despite lifestyle changes, pharmacologic therapy is initiated. Insulin is the first‑line choice because it does not cross the placenta; rapid‑acting analogs address post‑prandial spikes and basal insulin (e.g., NPH) covers fasting needs. Oral agents are considered when insulin is not feasible: metformin has the most safety data and is weight‑neutral, while glyburide is an alternative but has higher placental transfer and may increase fetal insulin exposure. Therapy is individualized based on gestational age, severity, and patient preference.
Monitoring schedules typically include a fasting measurement upon waking, a 1‑hour reading after each main meal, and optionally a bedtime check. Target ranges are 70–95 mg/dL fasting, 100–140 mg/dL 1‑hour post‑meal, and ≤120 mg/dL 2‑hour post‑meal if used. Data are reviewed at prenatal visits every 2–4 weeks (more often if control is unstable) to adjust diet, activity, or medication. Continuous glucose monitoring (CGM) can provide real‑time trends and reduce the need for frequent finger‑sticks.
Although GDM usually resolves after delivery, women remain at higher risk for type 2 diabetes and cardiovascular disease. An oral glucose tolerance test is performed 6–12 weeks postpartum; if normal, repeat screening every 1–3 years. Ongoing recommendations include a balanced diet rich in whole grains, lean protein, and vegetables; at least 150 minutes of moderate exercise weekly; regular weight and waist‑circumference checks; and periodic HbA1c testing. Liv Hospital offers coordinated endocrinology follow‑up, nutrition counseling, and wellness programs to support long‑term health.
For international patients, Liv Hospital offers a dedicated multilingual team that handles appointment scheduling, airport transfers, interpreter services, and lodging options. The hospital’s JCI‑accredited facilities combine state‑of‑the‑art diagnostics with personalized treatment plans crafted by endocrinologists, obstetricians, dietitians, and diabetes educators. This comprehensive approach ensures culturally sensitive, seamless care from the first prenatal visit through postpartum follow‑up.
BlogDiabetes MellitusMay 14, 2026Understand what is glucose plasma, its normal range, and why fasting plasma glucose tests are the simplest,...
BlogDiabetes MellitusMay 14, 2026We explain what is an insulin injection kit used for, detailing its role in insulin therapy to support diab...
BlogDiabetes MellitusMay 14, 2026We explain what gland produces insulin and how it balances blood sugar with hormones like insulin, glucagon...
BlogDiabetes MellitusMay 14, 2026Understand what causes type 1 diabetes, including autoimmune triggers and environmental factors, with insig...
BlogEndocrinologyMay 14, 2026We provide clear insights on delayed puberty male, its common causes, and compassionate treatment to suppor...
BlogEndocrinologyMay 14, 2026Learn about the cause of hashimoto thyroid disease, including genetic and environmental factors. We provide...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 67 91